scholarly journals Personalized medication adherence management in asthma and COPD: a review of effective interventions and development of a practical adherence toolkit

Author(s):  
Susanne J. van de Hei ◽  
Boudewijn J.H. Dierick ◽  
Joyce E.P. Aarts ◽  
Janwillem W.H. Kocks ◽  
Job F.M. van Boven
2012 ◽  
Vol 26 (4) ◽  
pp. 376-381 ◽  
Author(s):  
Michelle N. Mangan ◽  
Mary F. Powers ◽  
Aaron J. Lengel

Purpose: To identify the barriers perceived by student pharmacists to counseling on medication adherence in a supermarket community pharmacy chain. Methods: Online surveys were made available to 65 student pharmacists. Subjects completed the survey anonymously and indicated their opinions and perceptions on topics related to medication adherence through the use of a 5-point Likert-type scale. Results: Of the surveyed student pharmacists, 26 completed the survey (40%). All participants (100%) agreed that they have knowledge on the importance of medication adherence. Student pharmacists stated that they did not have the time to cover adherence in a counseling session (72.7%) nor did they have time to perform follow-up phone calls with the patient (54.5%). The majority of student pharmacists (81.8%) were comfortable bringing up the topic of adherence with the patient but thought that they did not have access to resources on adherence to provide to the patient (59%). Conclusions: Surveyed students indicated they were constrained for time to counsel patients on adherence and to perform continued follow-up with patients afterward. Factors cited as barriers to counseling patients on medication adherence include time, lack of specific training in adherence management, lack of resources to provide to the patient, and patient disinterest in the subject.


2021 ◽  
pp. bmjqs-2020-011671
Author(s):  
Andrea Torres-Robles ◽  
Shalom I Benrimoj ◽  
Miguel Angel Gastelurrutia ◽  
Fernando Martinez-Martinez ◽  
Tamara Peiro ◽  
...  

BackgroundNon-adherence to medications continues to be a burden worldwide, with significant negative consequences. Community pharmacist interventions seem to be effective at improving medication adherence. However, more evidence is needed regarding their impact on disease-specific outcomes. The aim was to evaluate the impact of a community pharmacist-led adherence management intervention on adherence and clinical outcomes in patients with hypertension, asthma and chronic obstructive pulmonary disease (COPD).MethodsA 6-month cluster randomised controlled trial was conducted in Spanish community pharmacies. Patients suffering from hypertension, asthma and COPD were recruited. Patients in the intervention group received a medication adherence management intervention and the control group received usual care. The intervention was based on theoretical frameworks for changing patient behaviour. Medication adherence, disease-specific outcomes (Asthma Control Questionnaire (ACQ) scores, Clinical COPD Questionnaire (CCQ) scores and blood pressure levels) and disease control were evaluated. A multilevel regression model was used to analyse the data.ResultsNinety-eight pharmacies and 1186 patients were recruited, with 1038 patients completing the study. Patients receiving the intervention had an OR of 5.12 (95% CI 3.20 to 8.20, p<0.05) of being adherent after the 6 months. At the end of the study, patients in the intervention group had lower diastolic blood pressure levels (mean difference (MD) −2.88, 95% CI −5.33 to −0.43, p=0.02), lower CCQ scores (MD −0.50, 95% CI −0.82 to −0.18, p<0.05) and lower ACQ scores (MD −0.28, 95% CI −0.56 to 0.00, p<0.05) when compared with the control group.ConclusionsA community pharmacist-led medication adherence intervention was effective at improving medication adherence and clinical outcomes in patients suffering from hypertension, asthma and COPD. Future research should explore the implementation of these interventions in routine practice.Trial registration numberACTRN12618000410257.


2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S347-S348
Author(s):  
Gregory S Felzien ◽  
Sean J McIntosh ◽  
Ekaterina S Taneva ◽  
Laura Simone ◽  
Laurence Greene ◽  
...  

Abstract Background Many studies have identified barriers to achieving goals for HIV care, thereby informing various intervention strategies. However, whether a given strategy can effectively overcome key barriers may depend on the extent to which patients and healthcare professionals (HCPs) agree that it is useful. To address this gap, we conducted a survey study to compare patients’ and HCPs’ perceptions of strategies for promoting HIV prevention, medication adherence, and care retention. Methods The survey was administered to patients and their HCPs as part of collaborative educational programs held in 12 community clinics in urban and suburban areas across 6 southeastern states. Participants included each clinic’s staff and their patients living with or at risk for HIV infection. The surveys listed 12 strategies for overcoming barriers to HIV prevention, adherence, and retention. Patients and HCPs rated the extent to which each strategy would be helpful for achieving desired goals (scale: 1 = very unhelpful to 5 = very helpful). We conducted χ 2 or Fisher’s exact tests to assess between-group differences in the frequency of pooled ratings of 4 (helpful) and 5 (very helpful). Results Surveys were completed by 224 patients (69% with HIV diagnosis, mean age 47 years, 42% women, 75% African American) and 39 HCPs (42% health educators/counselors, 31% nurse practitioners, 24% social workers, 3% physicians). Among other findings (Figures 1–3), similar percentages of patients and HCPs, respectively, gave ratings of 4 or 5 for taking pills (PrEP) that prevent HIV (83%, 80%); using a smartphone app with medication reminders (78%, 74%); and making it easier to get clinic appointments (90%, 85%). More discordant perceptions, all reflecting lower percentages of 4 or 5 ratings among patients than HCPs, were evident for talking with a counselor (82%, 90%); getting support from friends and family (82%, 92%); and improving relationships with clinic staff (85%, 100%). Conclusion These findings may inform interventions that are perceived by both patients and HCPs to be helpful for promoting HIV prevention, medication adherence, and retention. Effective interventions must address any discordance between patients and HCPs in the usefulness of selected strategies. Disclosures All authors: No reported disclosures.


2019 ◽  
Vol 18 (4) ◽  
pp. 207-213
Author(s):  
Cynthia L. Foronda ◽  
Sadandaula Rose Muheriwa ◽  
Margo Fernandez-Burgos ◽  
Susan Prather ◽  
Paula Nersesian

Introduction: There are significant disparities in medication adherence among underserved minority groups such as Latinos. Adherence to medication is a primary determinant of treatment success. Little is known about medication adherence among Latino children. This integrated review aims to describe what is known about medication adherence among Latino children and explore barriers and facilitators to medication adherence. Method: This review was guided by Whittemore and Knafl’s method of integrative review and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement. Results: Of the 20 articles reviewed about medication adherence among Latino children, the analysis of these articles revealed four major themes: (1) low adherence, (2) low adherence associations, (3) child outcomes, and (4) effective interventions. Conclusion: Health practitioners should consider medication adherence associations and interventions when collaborating with the family caregiver to improve child outcomes.


2014 ◽  
Vol 4 (1) ◽  
pp. 29-48 ◽  
Author(s):  
Joni L Strom Williams ◽  
Rebekah J Walker ◽  
Brittany L Smalls ◽  
Jennifer A Campbell ◽  
Leonard E Egede

Healthcare ◽  
2021 ◽  
Vol 9 (10) ◽  
pp. 1282
Author(s):  
Zoe Bond ◽  
Tanya Scanlon ◽  
Gaby Judah

Statin non-adherence is a common problem in the management of cardiovascular disease (CVD), increasing patient morbidity and mortality. Mobile health (mHealth) interventions may be a scalable way to improve medication adherence. The objectives of this review were to assess the literature testing mHealth interventions for statin adherence and to identify the Behaviour-Change Techniques (BCTs) employed by effective and ineffective interventions. A systematic search was conducted of randomised controlled trials (RCTs) measuring the effectiveness of mHealth interventions to improve statin adherence against standard of care in those who had been prescribed statins for the primary or secondary prevention of CVD, published in English (1 January 2000–17 July 2020). For included studies, relevant data were extracted, the BCTs used in the trial arms were coded, and a quality assessment made using the Risk of Bias 2 (RoB2) questionnaire. The search identified 17 relevant studies. Twelve studies demonstrated a significant improvement in adherence in the mHealth intervention trial arm, and five reported no impact on adherence. Automated phone messages were the mHealth delivery method most frequently used in effective interventions. Studies including more BCTs were more effective. The BCTs most frequently associated with effective interventions were “Goal setting (behaviour)”, “Instruction on how to perform a behaviour”, and “Credible source”. Other effective techniques were “Information about health consequences”, “Feedback on behaviour”, and “Social support (unspecified)”. This review found moderate, positive evidence of the effect of mHealth interventions on statin adherence. There are four primary recommendations for practitioners using mHealth interventions to improve statin adherence: use multifaceted interventions using multiple BCTs, consider automated messages as a digital delivery method from a credible source, provide instructions on taking statins, and set adherence goals with patients. Further research should assess the optimal frequency of intervention delivery and investigate the generalisability of these interventions across settings and demographics.


Pharmaceutics ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 1100
Author(s):  
Kirsi Kvarnström ◽  
Aleksi Westerholm ◽  
Marja Airaksinen ◽  
Helena Liira

Introduction: Medication adherence continues to be a significant challenge in healthcare, and there is a shortage of effective interventions in this area. This scoping review studied the patient-related factors of medication adherence. Methods: We searched Medline Ovid, Scopus, and Cochrane Library from January 2009 to June 2021 to find the most recent original qualitative studies or systematic reviews that addressed the patient-related factors of medication adherence in treating chronic conditions. We used the PRISMA-ScR checklist to ensure the quality of the study. Results: The initial search revealed 4404 studies, of which we included 89 qualitative studies in the scoping review. We inductively organized the patient-related factors causing barriers, as well as the facilitators to medication adherence. The studies more often dealt with barriers than facilitators. We classified the factors as patient-specific, illness-specific, medication-related, healthcare and system-related, sociocultural, as well as logistical and financial factors. Information and knowledge of diseases and their treatment, communication, trust in patient-provider relationships, support, and adequate resources appeared to be the critical facilitators in medication adherence from the patient perspective. Discussion and conclusions: Patients are willing to discuss their concerns about medications. Better communication and better information on medicines appear to be among the critical factors for patients. The findings of this scoping review may help those who plan further interventions to improve medication adherence.


Author(s):  
Muhammad Amir ◽  
Mehwish Rizvi ◽  
Zeb-un nisa ◽  
Rafi Akhtar Sultan ◽  
Maqsood Ahmed Khan ◽  
...  

It is not new in medical history to propose a global concern to be classified as a disease. Defining a concern into disease allows to assign ethical responsibilities to develop powerful and effective interventions. It also allow to appropriate distribute the resources uniformly economically and morally. In 2003, World Health Organization report stated that 30-50 % of patients do not take their medications as prescribed associated with morbidity, mortality and health cost. It was considered a global concern, however, irrespective of decades of researches conducted on medication adherence, we are still unable to state that medication adherence issues are being resolved. In this review, we have described few apprehensions in current understandings of medication adherence that have limited its research. We have also proposed medication adherence as disorder and provided its&rsquo; definition and classification


Sign in / Sign up

Export Citation Format

Share Document